NewAmsterdam Pharma Co N.V.

NAMS

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001936258

SEC filings (opens in a new tab)

In the last 90 days, NewAmsterdam Pharma Co N.V. insiders filed 1 open-market purchase and 4 sales; 194 institutions reported holding it in 13F filings for Q2 2026, worth $4.13B in total; 3 superinvestors hold it, including Viking Global Investors and Maverick Capital.

Other share classesNAMSW

Q2 2024 vs. Q1 2024

How the institutions holding NewAmsterdam Pharma Co N.V. changed between Q1 2024 and Q2 2024.

All holders in Q2 2024 All holders in Q1 2024

13F holders of NAMS: Q1 2024 compared with Q2 2024
Measure	Q1 2024	Q2 2024	Change
Holders	76	90	+14
Shares	72.2M	72.0M	−142.1K (−0.2%)
Value	$1.71B	$1.38B	−$323.0M (−18.9%)

New holders (24)

Institutions that held NewAmsterdam Pharma Co N.V. at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to NAMS in Q2 2024
Institution	Shares	Value	% of portfolio
Woodline Partners LP	483,388	$9.29M	0.09%
Decheng Capital LLC	400,000	$7.68M	2.35%
Standard Life Aberdeen plc	76,000	$1.46M	0.00%
Superstring Capital Management LP	64,213	$1.23M	1.55%
Gsa Capital Partners LLP	36,906	$709.0K	0.05%
Swiss National Bank	35,100	$674.3K	0.00%
Vestal Point Capital, LP	25,000	$480.3K	0.04%
Acuta Capital Partners, LLC	22,500	$432.2K	0.36%
UBS Asset Management Americas Inc	17,978	$345.4K	0.00%
California State Teachers Retirement System	16,195	$311.1K	0.00%
Legal & General Group Plc	15,836	$304.2K	0.00%
State Street Corp	14,110	$271.1K	0.00%
Parkwood LLC	13,782	$265.0K	0.03%
Vanguard Group Inc	13,445	$258.3K	0.00%
State of Wisconsin Investment Board	12,171	$233.8K	0.00%
Kennedy Capital Management, Inc.	11,853	$227.7K	0.00%
Rosalind Advisors, Inc.	10,123	$194.5K	0.15%
Virtus ETF Advisers LLC	4,657	$89.5K	0.04%
The PNC Financial Services Group, Inc.	2,674	$51.4K	0.00%
Banque Cantonale Vaudoise	2,000	$38.0K	0.00%
Parallel Advisors, LLC	1,000	$19.2K	0.00%
Global Retirement Partners, LLC	393	$7.55K	0.00%
Quarry LP	253	$4.86K	0.00%
Advisor Group Holdings, Inc.	45	$864	0.00%

Sold out (10)

Institutions that held NewAmsterdam Pharma Co N.V. at the end of Q1 2024 and filed for Q2 2024 without it.

Institutions that sold out of NAMS in Q2 2024
Institution	Shares, Q1 2024	Value, Q1 2024
Octagon Capital Advisors LP	408,000	$9.65M
Perceptive Advisors LLC	175,000	$4.14M
Nantahala Capital Management, LLC	175,000	$4.14M
Monashee Investment Management LLC	170,000	$4.02M
Silverarc Capital Management, LLC	99,612	$2.36M
StemPoint Capital LP	80,334	$1.90M
Lighthouse Investment Partners, LLC	29,357	$694.3K
Cubist Systematic Strategies, LLC	22,993	$543.8K
Two Sigma Advisers, LP	9,100	$215.2K
Canton Hathaway, LLC	1,000	$24.0K